Immunotherapy and Targeted Treatments for mNSCLC: Some Updates from ESMO 2022
Presentation by Neal Ready, MD, PhD, Duke Health at ESMO22 Pennsylvania. Treatment of patients with metastatic, non-small cell lung...
top of page
- Oct 31, 2022
- 3 min
What’s New in Small-Cell Lung Cancer: A Quick Update from ESMO 2022
Paul Bunn, MD, University of Colorado, presents during the first-ever US-based ESMO Series – 2022 ESMO Colorado. At this year’s...
- Oct 27, 2022
- 3 min
Immunotherapy as an Alternative to Chemotherapy in the Elderly Lung Cancer Patient: IPSOS Trial
Dr. Solange Peters, President of the European Society for Medical Oncology, presents during the first-ever US-based ESMO Conference –...
bottom of page